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Craniocerebral trauma is one of the causes of raised intracra-
nial pressure (ICP) the control and course of which have a 
critical bearing on morbidity and mortality in headinjured 
patients. At least 50 percent of patients who die from head 
injury do so from uncontrollable raised ICP (I). 
PATHOPHYSIOWGICAL CONSIDERATIONS 
The skull is a rigid container which holds a fixed volume of 
brain matter, cerebrospinal fluid (CSF) and circulating 
blood. Neurones and glia make up 1200 to 1600 ml of the 
volume of intracranial content, with CSF and circulating 
blood each accounting for about 100 to 150 ml; there is a 
small amount, about 50 ml, of extra~cellular fluid in the 
intracranial cavity (2). 
The brain, CSF and b~od maintain a dynamic equilibri-
um, such that a change in the volume of any of them is off-
set by a reciprocal alteration in ~e amounts of the other ele-
ments such that ICP remains wat4in normal (3). In head 
injury, it is the brain volume which increases, due either to 
the development of an intracranial ha:ematoma or of brain 
oedema or a combination of both. The brain oedema is usu-
ally vasogenic in origin, due to disruption of the blood-brain 
barrier and characterised by protein-rich fluid. It begins in 
the grey matter where most of the blood vessels lie, and then 
spreads to the white matter which, because of its greater tis-
sue compliance, ultimately accommodates more water than 
the grey matter (4). 
Compensatory mechanisms come into play in the early 
stages of head injury to keep the ICP within normal limits 
(between -3 and +15 mmhg or -5 and +25 em H20). As 
brain volume increases, CSF is reduced either by rcdu~ 
production or incr~ absorption and cerebral blood flow 
diminishes. These changes are dependent on the elasrance or 
stiffness of the brain. If brain volume continues to rise 
unchecked, these compensatory mechanisms break down 
and raised ICP becomes established. 
MEASUREMENT OF ICP 
The classical features of intracranial hypettension are often 
unreliable in head injury, which makes the objective mea-
surement of ICP necessary in its management. Headache is 
not common in the early stages of head injury and it rarely 
occurs in the first few days of moderate to severe brain injury 
even when the patient can complain. Vomiting occurs in 
head injuries with or without raised ICp, and papilloedema 
takes a few days to develop (5). 
Lumbar puncture offers a simple method of measuring 
ICP by recording the pressure in the lumbar subarachnoid 
space using a manometer. There are, however, limitations 
and dangers. it gives a single reading which can be mislead-
ing. It reflects the ICP only when there is free communica-
tion between the lumbar and intracranial subarachnoid 
spaces. The procedure can cause tentorial or cerebellar ton-
sillar herniation, particularly when there is posterior fossa 
lesion, and without reflection of the supratentorial ICP. 
Lumbar puncture is therefore contraindicated in head injury; 
it shouIJ b~ tilJ1Je IlS a dUzgnostic proudurt: when thm is a sus-
picion of meningitis. 
The basic requirements for continuous lCP measurmzmt, 
the development of the technique, its clinical applications 
and the merits and demerits of the various methods used 
have been extensively reviewed (6, 7). The three standard 
methods used for continuous measurement are atratJuraJ. 
subarachnoitl/subdural and intravmtricul4r. 
In the extradural monitoring, which is exemplified by the 
Ladd equipment, the sensor is usually positioned in direct 
contaCt with the dura (8); in infants, the Ladd sensor occa-
sionally changes position especially if the extradural space is 
capacious and it tends to give higher ICP readings than the 
other two methods. The extradural technique, on the other 
hand, has the advantages of ease of insenion, simplicity of 
management and freedom from causing inrracran;t infec-
tion. .,.s 
Catheters or screws are used for subarachnoid and sub-
dural ICP measurement (10) . The catheters cause leakage of 
CSF and may provoke infection. The screws (Leeds or 
Richmond type) are easily positioned through burr holes 
without puncturing the brain; however, they tend to under-
read ICP at pressures above 20 mmhg (II). 
Intraventricular pressure recording, the original method 
used by Lundberg (12) one of the pioneers ofICP measure-
ment, is generally accepted to be the most accurate method 
of measurement. It allows repeated withdrawal and examina-
tion of CSF, if required. Its disadvantages include the diffi-
culty of positioning the catheter if the ventricle is displaced 
or compreSsed, as may happen in severe head injuries with 
brain oedema, and the risks of intracranial infection and 
haemorrhage. Recently a bedside percutaneous technique of 
intraventricular ICP monitoring in children has been intro-
duced in Glasgow, Scotland (13). 
Coma Score (GCS) of 3 to 5; in those with GCS of 6 to 
8 with abnormal computed tomography(CT) scans and oth-
ers with moderately severe injuries with neurological deficits 
or deterioration (14). It is also indicated in patients with ini-
tially nonnal cr scan but who are considered to be at risk of 
developing raised ICP. These high risk patients include those 
aged over 40 years; patients with systolic blood pressure of 
under 90 mmhg and those with motor posturing (15) 
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with ICP sustained over 40 mmhg rarely survive. It is also 
useful in controlling diuretic therapy and it may warn the 
clinician of an incipient expanding intracranial lesion. 
TREATMENT OF RAISED ICP 
A. SPEOFIC MEASURES. Some simple well known mea-
sures can com:ct raised ICP. Ensuring that the patient has a 
clear air-way and that there is no kinking of the neck with 
consequent jugular vein compression can relieve raised ICP. 
A known cause of elevated ICP in head injury is intracra-
nial haematoma; surgical evacuation of the latter usually cor-
rects the ICP. 
Often in head injury, a specific cause of the elevated ICP 
is not found, or if found it may coexist with significant brain 
oedema. The management of postraumatic brain oedema is 
summarised as follows: 
B. CARE OF BRAIN OEDEMA 
1. READ ELEVATION 
The head-end of the bed is raised to about 30 degrees, taking 
care not to kink the neck or compress the jugular vein. This 
position promotes cerebral venous drainage and decreases 
intracranial venous pressure and ICP. The measure should 
not be taken if there is peripheral circulatory failure. 
2. HYPERVENTILATION 
Controlled ventilation is one of the most effective measures 
of reducing pain oedema and hence of elevated ICP. The 
patient is sedated and placed on analgesia and muscle relax-
ant and connected to an automatic ventilator which is 
adjusted to keep the pC02 at about 25 to 30 mmHg, (3.3-
4kPa). 
Mechanism. Hyperventilation lowers arterial pC02 and 
causes cerebral vasoconstriction leading to 
diminished cerebral blood flow and reduced 
ICP. 
Hyperventilation may reduce the rate of CSF formation 
(16). It may also promote a shift of water between the 
intracranial companments described above and lead to excre-
tion of water by the CSF (5). 
Clinical Benefits. The beneficial effect of hyperventilation is 
almost immediate and most marked in 
the ac~lte stage of head injury. As a rule, 
there is noticeable reduction in ICP with-
in about 10 minutes of initiating hyper-
ventilation, so that the earlier it is starred 
in severe head injury, the better the out-
come. 
Limitations. The vasoconstrictive effect of low pC02 
occurs in areas of the brain with normal blood 
vessels and intact autoregulation mechanisms; 
damaged vessels do not respond as well. 
If the anerial pC02 is too low, say below 20 mmHg (2.7 
kPa) for a long time, hypoxia may develop. 
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With prolonged hyperventilation, the cerebral blood flow, 
which was initially reduced, tends to return to normal; alve-
olar collapse in the lung can also occur. Hyperventilation 
need not be maintained longer than a week to 10 days; 
Crockard et aI (17) found that if there was no improvement 
in the level of consciousness of the patient after that period, 
further hyperventilation produced patients who survived to 
lead a vegetative existence. If ICP remains elevated and 
hyperventilation is continued, the ICP may actually rise fur-
ther. 
3. DIURETIC THERAPY 
Osmotherapy. Mannitol, with a molecular weight of 180 is 
the most widely used osmotic diuretic. If 
hyperventilation fails to bring the ICP down 
to 25 mmhg or 35 em H20, mannitol should 
be staned without delay. 
It is given intravenously in a 20 percent solution, the 
dosage being between 1 and 3 grams per kilogram body 
weight, in a bolus over 10 to 15 minutes. It can be repeated 
in smaller dosages, the total amount given in a period of 
about one hour. Strict fluid and elecrrolyte balance must be 
maintained, keeping the serum osmolality below 320 
m.molli. 
Mode of Action. Mannitol establishes an 9smotic gradient 
between plasma and the brain parenchyma 
to the blood. As a result, there is an over-all 
decrease in the volume of normal brain 
water, leading to a reduction of intracranial 
pressure. 
Mannitol is panicularly active in parts of the brain where 
the blood-bcain barrier is intact; in damaged areas of the 
brain with deranged autoregulation, mannitol is ineffecrive 
and passes into the extravascular space (18). 




Raise head end of bed to 30 degrees provided 
there is no circulatory failure. 
Intubate and hyperventilate to an arterial car-
bon dioxide tension of 25 - 30 mmHg (3.3-
4kPa). 
Give mannitol as a drip (20% solution) at 1 -
3g/kg body weight in patients with a lateralis-
ing pupil or motor response. 
Limitation. Osmotherapy with mannitol has its drawbacks. 
The effect is short, lasting about 3 to 4 hours. 
When it is discontinued, a rebound rise in ICP 
may occur. Repeated doses become less effective 
and may cause extreme diuresis, severe dehydra-
tion, hypotension, tachycardia, and in some 
cases acidosis and renal failure (19). 
Accumulation of mannitol in the damaged areas of the 
brain often worsens the brain oedema; excessive dosages 










































Loop Diu"tie. Furosemide (Lasix) is most commonly used. 
It is a sulphonamide diuretic which inhibits 
distal tubular reabsorption of electrolytes. Its 
beneficial effect on raised ICP is exerted first-
ly by reduction of sodium and water migra-
tion across the blood-brain barrier. and sec-
ondly. by reduced formation of CSF through 
carbonic anhydrase inhibition in the choroid 
plexus. 
The advantages of furosemide over mannitol include lack 
of rebound rise of ICP after its use and less changes in elec-
trolytes and osmolality. It is given either alone or in addition 
to mannitol in a dose of 1 mg per kilogram body weight. 
Other Agents Used 
U"4 was the first effective hyperosmotic diuretic used. given 
in a dosage of 1 to 1.5 gm per kilogram body weight. 
but has now been replaced by mannitol in clinical prac-
tice. Like mannitol. it is excreted unchanged in the 
urine and has a rebound effect on ICP. It also increas-
es blood urea nitrogen and arterial blood pressure. 
Glyurol a trivalent alcohol may be given intravenously in a 
10 percent solution at a dosage of 1 gm per kilo-
gram body weight. infused at the rate of 5 ml per 
minute. It may also be given by mouth or through 
a nasogastric tube. 
There is comparatively little experience with its use in 
clinical practice. The beneficial effect on reducing ICP lasts 
about 12 hours; its side effects include depletion of elec-
trolytes and blood cells. and causing thrombosis in the ves-
seis used for its intravenous infusion (5). 
50 p"emt Dcarou. It has been found that some patients 
with severe brain oedema who are 
refractory to mannitol respond to intra-
venous administration of 50 percent 
dextrose (14). The pressure lowering 
effect of the latter is. however. shortlast-
ing. 
4. CSF DRAINAGE 
This is a simple and effective method of reducing ICP.; In 
head injured patient whose ICP is monitored through an 
indwelling intraventricular catheter. removal of a small 
amount of CSF can prompdy and dramatically lower the 
.!CP. 
CSF withdrawal establishes a beneficial pressure gradient 
from the swollen brain to the ventricles. leading to move-
ment of water to the ventricles and thus to the resolution of 
the oedema of the brain (18). 
The technique has its limitations. Thus. its benefits are 
transient. so that repeated or continuous withdrawal has to 
be carried out with the attendant risk of infection. Also. the 
ventricular wall may collapse and consequently kink or block 
the catheter. The latter contingency can be prevented if the 
CSF drainage is carried out at an intracranial pressure level of 
not less than 10 to 15 mmHg. 
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CSF drainage is contraindicated in the presence of unilat-
eral hydrocephalus as the procedure may worsen any existing 
midline shifr. 
5. CORTICOSTEROIDS 
About three decades ago. it was observed that corticos-
teroids effectively reduced the brain oedema around intracra-
nial tumours and brain abscesses and that following cran-
iotomy (20). Thereafter. their usage was extended to the 
management of the brain oedema which occurs in head 
injury. How corticosteroids reduce brain oedema is not 
known exacdy. but it is ascribed to preservation of cell mem-
brane integrity and the blood-brain barrier through stabilisa-
tion of lyzosomal enzymes. 
The universally employed drug is tkxamtthason~ which is 
more potent than other steroids and relatively free of pro-
voking salt and water retention. The initial adult dosage is 
10 mg given intravenously and followed by 5 mg 6 hourly 
and subsequendy in diminishing doses for about a week or 
more until there is evidence of ICP reduction. This regime 
is still used in many trauma centres. mosdy by doctors other 
than neurosurgeons. with simultaneous administration of 
antacids to counteract that most dreaded complication of 
steroid therapy. namely. gastric haemorrhage. 
Nevertheless. the beneficial effect of dexamethasone in 
reducing elevated ICP in severe head injury is now contro-
versial. The initial animal experiments on the place of 
steroids in head injury treatment gave conflicting and incon-
sistent results (21). The claim that glucocorticoids reduced 
CSF production in dogs (22) was disproved by others (23). 
To be effective. it was suggested that corticosteroids should 
be given before injury but the benefits were not noticeable 
until about 19 to 24 hours after administration. implying 
that steroids cannot be useful for the immediate trodtment of 
acute brain oedema. .;I 
The earlier clinical trials showed better clinical outcome in 
patients with diffuse brain injury treated with dexametha-
sone than those without it. The results were considered unre-
liable because those trials were uncontrolled. The first double 
blind controlled study which compared placebo with low 
dose and high dose dexamethasone in severe head injury 
showed reduced morbidity and mortality in the steroid treat-
ed patients. especially among those on megadosages (over 
100 mg in the first 24 hours afrer head injury). 
These positive claims were not supported by the prospec-
tive double blind controlled trials carried out in the last ten 
years (24. 25). These recent studies showed that steroids 
increased the susceptibility of the head injured patient to gas-
tric haemorrhage. hyperglycaemia. pulmonary infection and 
negative nitrogen balance. Some series which had the oppor-
tunity of postmortem examination of fatal cases of severe 
head injury reported that the anatomical damage was con-
siderable enough that at least 90 percent of the deaths could 
not have been prevented by steroids (26). Jooma in an exten-
sive editorial review concluded that "dexamethasone confers 
no benefit to the seriously head injured patient and may 
infact be harmful" (21). 
6. BARBITURATES 
Pentobarbitone-induced coma may be useful when ICP fails 
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How it works is unknown for sure, but the method was sug-
gested by the observation that thiopentone sometimes 
sharply reduces ICP during anaesthesia (28). What is known 
is that barbiturate depresses cerebral metabolic activity and 
hence reduces blood flow to the normal parts of the brain, 
leading to more blood supply to the damaged areas. 
The dosage used is 3 to 5 mg per kilogram body weight, 
ensuring a blood level of 2. 5 to 3. 5 mg per dI. The use of 
barbiturate-induced coma in reducing raised ICP is a major 
management procedure which needs all the sophistication of 
an up-to-date intensive care unit (3). 
7. HYPOTHERMIA 
This also aCts by reducing cerebral metabolism and bio-
chemical reactions in the brain. James et aI (29) found that 
hypothermia of 27 to 360 C could reduce the ICP by about 
50 percent; however, this pressure-lowering effect is not con-
sistent. 
In practice, hypothermia is not to be used alone; with bar-
biturates (400 mg pentobarbitone in adults and 150 mg in 
children) it has an additive effect in lowering elevated ICP 
unresponsive to other forms of treatment. Hypothermia is 
not recommended for longer than five days, otherwise, com-
plications such as pneumonia and gastrointestinal haemor-
rhage may occur. 
8. HYPERBARIC OXYGEN 
How hyperbaric oxygenation reduces raised ICP is not 
known, but experimental and clinical evidence suggests that 
it may reduce ICP by as much as 30 percent (30). This occurs 
only in patients with intact cp.rebral autoregulation mecha-
nisms; the method is effective only when applied within 
about 30 minutes of the head injury. 
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There are other limitations. Thus, it is difficult to nurse 
the head injured patient in a hyperbaric chamber. Once 
hyperbaric oxygenation is stopped, there may be a rebound 
rise in intracranial pressure. When the ICP is high, this 
method is ineffective. 
9. SURGICAL DECOMPRESSION 
The last reson for dealing with intractably high ICP in 
severe head injury is surgical decompression of the intracra-
nial companment by either subtemporal or suboccipital 
craniotomy or by the more radical surgical removal of parts 
of the calvarium. These heroic measures have largely fallen 
into disrepute (5). 
SUMMARY 
Head injury is one of the important causes of raised intracra-
nial pressure (ICP) provoked by either intracranial 
haematoma or brain oedema or a combination of both. 
Continuous measurement of ICP is performed by either the 
extradural, subdural or the ventricular technique. The usual 
methods of reducing elevated ICP include the maintenance 
of an adequate of an adequate airway; prompt removal of any 
significant intracranial haematoma; head elevation when not 
contraindicated by shock; controlled ventilation; use of 
diuretics and sometimes of dexamethasone and where feasi-
ble CSF withdrawal by the ventricular route. In resistant 
cases, aggressive measures by barbiturate induced coma com-
bined with hypothermia, hyperbaric oxygenation and surgi-
cal decompression may be used. 
(References are available from the author on request) 
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